Xiamen Amoytop Biotech: Announcement on the approval of the drug clinical trial approval letter for the newly approved indications of Pegintron.
Xiamen Amoytop Biotech: Investor Relations Activity Record (June 18, 2024)
Xiamen Amoytop Biotech: Director's shareholding reduction announcement.
Xiamen Amoytop Biotech: Investor Relations Activity Schedule (May 22, 2024)
Xiamen Amoytop Biotech: Investor Relations Activity Schedule (May 16, 2024)
Xiamen Amoytop Biotech: 2023 Annual Equity Distribution Implementation Notice
Xiamen Amoytop Biotech: Announcement on participating in the 3rd “Improving Quality, Efficiency, and Reward” special session of the Science and Technology Innovation Board's 2023 Group Results Briefing
Xiamen Amoytop Biotech: Voluntary disclosure notice on the proposed inclusion of additional indications for Pegobin in the priority review process
Xiamen Amoytop Biotech: Announcement on participating in the 2023 Annual Report Performance Briefing and Online Investor Reception Day for Listed Companies in the Xiamen Area
Xiamen Amoytop Biotech: 2023 Annual General Meeting of Shareholders Legal Opinions
Xiamen Amoytop Biotech: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Tebao Biotech: Report for the first quarter of 2024
Tebao Biotech: Investor Relations Activity Record Form (2023 Biological Products Special Group Performance Briefing)
Tebao Biotech: 2023 Annual General Meeting of Shareholders Meeting Information
Tebao Biotech: Guojin Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Tebao Biotech
Tebao Biotech: Voluntary Disclosure Notice on Passing High-tech Enterprise Certification
Tebao Biotech: Announcement on participating in the 2023 Biological Products Special Group Performance Briefing
Tebao Biotech: Notice on holding the 2023 Annual General Meeting of Shareholders
Tebao Biology: Summary Report of Guojin Securities Co., Ltd. on the continuous supervision and sponsorship of the initial public offering of shares of Xiamen Tebao Bioengineering Co., Ltd. and its listing on the Science and Technology Innovation Board
Tebao Biotech: Investor Relations Activity Record Form (April 1, 2024)
No Data